Sylviane Villette

Summary

Affiliation: Centre Oscar Lambret
Country: France

Publications

  1. ncbi Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study
    David Knobel
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    BMC Cancer 6:118. 2006
  2. ncbi Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
  3. ncbi Phyllodes tumor of the breast
    Yazid Belkacemi
    Centre Oscar Lambret, Lille, France
    Int J Radiat Oncol Biol Phys 70:492-500. 2008
  4. ncbi Metabolic functional imaging for tumor radiosensitivity monitoring
    Yazid Belkacemi
    Department of Radiation Oncology, Oscar Lambret Anti Cancer Center and University of Lille II, Lille, France
    Crit Rev Oncol Hematol 62:227-39. 2007
  5. ncbi [The contribution of PET to radiation treatment planning]
    Yazid Belkacemi
    CRLCC Oscar Lambret, Département universitaire d oncologie radiothérapie, 3 Rue Frederic Combemale, 59020 Lille
    Bull Cancer 94:99-108. 2007
  6. ncbi Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation
    Yazid Belkacemi
    Department of Radiation Oncology, Oscar Lambret Center and University of Lille II, Lille, France
    Int J Radiat Oncol Biol Phys 67:544-51. 2007
  7. ncbi [HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]
    Yazid Belkacemi
    Département d Oncologie Radiothérapie, CRLCC Oscar Lambret, Lille
    Bull Cancer 93:991-9. 2006
  8. ncbi [Prognostic factors and management of rare cancers]
    Y Belkacemi
    Départements d Oncologie Radiothérapie et de Sénologie, CLCC Oscar Lambret et Faculté de Médecine, Universite de Lille II, 3, rue Frederic Combemale, Lille, France
    Cancer Radiother 10:323-9. 2006
  9. ncbi [Accelerated partial breast irradiation: a concept to individualize treatment in breast cancer]
    Y Belkacemi
    Departement de Radiotherapie, Centre Oscar Lambret, 3, rue Frederic Combemale, 59020, Lille, France
    Cancer Radiother 11:287-95. 2007
  10. ncbi [Assessment of tumor radiosensitivity using functional and metabolic nuclear imaging in research and clinical practice. A review]
    Y Belkacemi
    Département universitaire de radiothérapie, Centre Oscar Lambret, 3, rue Frederic Combemale, 59020, Lille, France
    Cancer Radiother 10:124-33. 2006

Collaborators

Detail Information

Publications32

  1. ncbi Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study
    David Knobel
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    BMC Cancer 6:118. 2006
    ..Therefore, in this large retrospective study, we wanted to assess the outcome, prognostic factors, and the optimal RT dose in patients with SP...
  2. ncbi Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
    ..To asses the clinical profile, treatment outcome and prognostic factors in primary breast lymphoma (PBL)...
  3. ncbi Phyllodes tumor of the breast
    Yazid Belkacemi
    Centre Oscar Lambret, Lille, France
    Int J Radiat Oncol Biol Phys 70:492-500. 2008
    ..To better identify prognostic factors for local control and survival, as well as the role of different therapeutic options, for phyllodes tumors, a rare fibroepithelial neoplasm of the breast...
  4. ncbi Metabolic functional imaging for tumor radiosensitivity monitoring
    Yazid Belkacemi
    Department of Radiation Oncology, Oscar Lambret Anti Cancer Center and University of Lille II, Lille, France
    Crit Rev Oncol Hematol 62:227-39. 2007
    ..We present here a critical review of the radiotracers revealed by nuclear imaging that are developed for radiosensitivity monitoring...
  5. ncbi [The contribution of PET to radiation treatment planning]
    Yazid Belkacemi
    CRLCC Oscar Lambret, Département universitaire d oncologie radiothérapie, 3 Rue Frederic Combemale, 59020 Lille
    Bull Cancer 94:99-108. 2007
    ..The contribution of PET imaging advances using FDG or new tracers for treatment planing in the new era of image guided radiation therapy will be discussed in this review...
  6. ncbi Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation
    Yazid Belkacemi
    Department of Radiation Oncology, Oscar Lambret Center and University of Lille II, Lille, France
    Int J Radiat Oncol Biol Phys 67:544-51. 2007
    ..A reduced intensity regimen can allow engraftment of stem cells and subsequent transfer of immune cells for the induction of a graft-vs.-tumor reaction...
  7. ncbi [HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]
    Yazid Belkacemi
    Département d Oncologie Radiothérapie, CRLCC Oscar Lambret, Lille
    Bull Cancer 93:991-9. 2006
    ..In this article, the advantages and uncertainties on efficacy and toxicities of the trastuzumab administration modalities, associated or not to chemotherapy and radiation therapy, are discussed...
  8. ncbi [Prognostic factors and management of rare cancers]
    Y Belkacemi
    Départements d Oncologie Radiothérapie et de Sénologie, CLCC Oscar Lambret et Faculté de Médecine, Universite de Lille II, 3, rue Frederic Combemale, Lille, France
    Cancer Radiother 10:323-9. 2006
    ..The network gathers more than 70 institutions from 21 countries. So far, 32 projects have been carried out. In this report we will discuss the most significant data provided by our group in several investigated diseases...
  9. ncbi [Accelerated partial breast irradiation: a concept to individualize treatment in breast cancer]
    Y Belkacemi
    Departement de Radiotherapie, Centre Oscar Lambret, 3, rue Frederic Combemale, 59020, Lille, France
    Cancer Radiother 11:287-95. 2007
    ..In this review, we will discuss the patients' profiles selection for APBI regarding their general and tumor criteria. The differences between APBI techniques either performed intra or post operatively will be also discussed...
  10. ncbi [Assessment of tumor radiosensitivity using functional and metabolic nuclear imaging in research and clinical practice. A review]
    Y Belkacemi
    Département universitaire de radiothérapie, Centre Oscar Lambret, 3, rue Frederic Combemale, 59020, Lille, France
    Cancer Radiother 10:124-33. 2006
    ..This would allow better tumor control rather than continue inefficient and costly treatment delivery, which in addition could compromise outcome...
  11. ncbi Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study
    Y Belkacemi
    Department of Radiation Oncology, CLCC Oscar Lambret Anti Cancer Center, University of Lille II, Lille, France
    Ann Oncol 19:1110-6. 2008
    ..The aim of this study was to evaluate the toxic effects of concurrent radiation therapy (RT) and T administration in the adjuvant setting...
  12. ncbi [Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MammoSite]
    Y Belkacemi
    Departement de Radiotherapie, Centre Oscar Lambret, 3, rue Frederic Combemale, BP 307, Universite de Lille II, 59020 Lille, France
    Cancer Radiother 7:129s-136s. 2003
    ..In this review we will focus on the MammoSite technique and will describe the per-operative implantation procedure, radiological controls ad dosimetric aspects...
  13. ncbi [Radiation protectants of the crystalline lens]
    Y Belkacemi
    Centre Oscar Lambret, Departement de Radiotherapie, 3, rue F Combemale, Universite de Lille II, 59020 Lille, France
    Cancer Radiother 7:49s-54s. 2003
    ..Amifostine (or Ethyol) and anethole dithiolethione (or Sulfarlem), already used clinically as chemo- and radioprotectants, could be further tested for ocular radioprotection particularly for radiation-induced cataract...
  14. ncbi Monitoring of residual hematopoiesis after total body irradiation in humans as a model for accidental x-ray exposure: dose-effect and failure of ex vivo expansion of residual stem cells in view of autografting
    Yazid Belkacemi
    Department of Radiation Therapy, Centre Oscar Lambret, Lille, France
    Int J Radiat Oncol Biol Phys 57:500-7. 2003
    ..We also investigated the possibility of expanding ex vivo the residual progenitors exposed to different dose levels of TBI...
  15. ncbi [Potential risk and benefit of the combination of trastuzumab to chemotherapy and radiation therapy in non-metastatic breast cancer]
    Y Belkacemi
    Département d Oncologie Radiothérapie, CLCC Oscar Lambret, Universite de Lille II, 3, rue Frederic Combemale, 59020 Lille, France
    Cancer Radiother 11:266-75. 2007
    ..The benefit/risk ratio of the concurrent and sequential administration of trastuzumab with chemotherapy and radiation therapy will be discussed in this review...
  16. ncbi Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Caroline Daveau
    Department of Radiation Oncology, Centre Rene Huguenin, Saint Cloud, France
    Int J Radiat Oncol Biol Phys 78:337-42. 2010
    ..We assessed the utility of lymph node irradiation (LNI) in breast cancer (BC) patients with pathologic N0 status (pN0) after NAC and breast-conserving surgery (BCS)...
  17. ncbi Is there a reliable method to assess the complete pathologic response on the tumor after neo-adjuvant chemotherapy in inflammatory breast cancer toward recommendations for the pathologic process? Experience in 56 patients treated in a single institution
    Audrey Mailliez
    Département de Sénologie, Centre Oscar Lambret, 3 Rue Frederic Combemale, Lille, France
    Breast J 16:464-71. 2010
    ..We propose a standardization of the pathologic process of the mastectomy specimens so that a CPR has a clear definition across the institutions, with a good reproducibility whatever the classification used...
  18. ncbi Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients
    E Touboul
    Department of Radiation Oncology, Centre des tumeurs, Tenon Hospital, 4 rue de la Chine, 75020 Paris, France
    Int J Radiat Oncol Biol Phys 50:81-97. 2001
    ..Results for patients with Stage III tumor are not satisfactory...
  19. ncbi [Follow-up of patients treated for localized invasive breast carcinoma]
    P Vennin
    Département de Sénologie, Centre Oscar Lambret, 3, rue Frederic Combemale, B P 307, 59020 Lille Cedex, France
    Gynecol Obstet Fertil 36:183-9. 2008
    ..But a systematic search for non-symptomatic metastases is unnecessary. We now need a coordination between practitioners to avoid useless tests, and to respond to patients' will...
  20. ncbi Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study
    Yazid Belkacemi
    Department of Radiation Oncology, Oscar Lambret Anti Cancer Center, Cedex, France
    Radiother Oncol 90:23-9. 2009
    ..Our objective was to evaluate the MammoSite device performances after an open cavity placement procedure and quality of life in highly selected patients with early-stage breast cancer...
  21. ncbi The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study
    Tan Dat Nguyen
    Department of Radiation Oncology, Institut Jean Godinot, Reims, France
    Radiother Oncol 77:286-9. 2005
    ..Our results suggest that similar local control in younger and older patients can be expected from either external beam radiotherapy or radical prostatectomy...
  22. ncbi Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network
    Guilhem Bousquet
    Oscar Lambret Anti Cancer Center, 3 Rue Frederic Combemale, Lille, France
    Radiother Oncol 85:355-61. 2007
    ..Breast sarcoma (BS) is a rare tumour. While surgical resection is the primary treatment, the role of radiation therapy (RT) and chemotherapy remains unclear. This study aimed at defining prognostic factors and treatment strategies...
  23. ncbi [Male breast cancer: a review]
    B Comet
    CRLC Oscar Lambret, Universite de Lille II, Lille, France
    Bull Cancer 96:181-9. 2009
    ..In the setting of considerable evolution in the management of women breast cancer, this review aimed to point out on the similarities and particularities of MBC and the future challenges to improve MBC outcome...
  24. ncbi [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art]
    D Azria
    Département d Oncologie Radiothérapie, CRLC Val d Aurelle, Rue Croix Verte, 34298 Montpellier Cedex 5, France
    Cancer Radiother 8:188-96. 2004
    ..The TEAM study compared exemestane (Aromasine) and tamoxifen, but specified that hormonal treatment follow the completion of radiation therapy...
  25. ncbi [Ductal carcinoma in situ: role of the boost]
    D Azria
    Departement de Radiotherapie, CRLC Val d Aurelle Paul Lamarque, Rue Croix Verte, 34298 Montpellier Cedex 5, France
    Cancer Radiother 12:571-6. 2008
    ..This protocol will start inclusions in October 2008...
  26. ncbi Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy
    Romuald Le Scodan
    Department of Radiation Oncology, Centre Rene Huguenin, 35 rue Dailly, 92210, Saint Cloud, France
    J Clin Oncol 27:1375-81. 2009
    ..Exclusive locoregional radiotherapy (LRR) is an alternative form of locoregional treatment (LRT) in this setting. We retrospectively studied the impact of LRT on the survival of breast cancer patients with synchronous metastases...
  27. ncbi [Breast adenocarcinoma: critical analysis of sentinel lymph node histopathological results of 542 procedures]
    Marie Christine Baranzelli
    Département d Anatomie Pathologique, Centre Oscar Lambret, 3, rue Combemale, BP 307, 59020 Lille Cedex
    Bull Cancer 92:983-7. 2005
    ..8% (36/44) of micrometastases were detected on the two first serial sections. Decisional value of axillary clearance performed in case of micrometastases is also evaluated...
  28. ncbi [Cancer diagnosis announcement: an act to seal the pact of trust between doctors and patients]
    Michel Reich
    Equipe de psycho oncologie, Centre Oscar Lambret, 3, rue Frederic Combemale, 59020 Lille BP 307, France
    Bull Cancer 95:841-7. 2008
    ..The respect of ethical principles will prevent incomprehension phenomena and seal the pact of trust between doctors and patients...
  29. ncbi [Accelerated partial breast irradiation in 2008: interrogations and perspectives]
    J M Hannoun-Levi
    Departement de Radiotherapie, Centre Antoine Lacassagne, 33, Avenue de Valombrose, 06189 Nice cedex, France
    Cancer Radiother 12:374-9. 2008
    ..However, clinical investigation conditions appear now different and this is this difference we have to manage rigorously and precisely...
  30. ncbi [How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?]
    D Azria
    Département d Oncologie Radiothérapie, INSERM U860, CRLC Val d Aurelle Paul Lamarque, Rue Croix Verte, Montpellier Cedex 5, France
    Cancer Radiother 12:37-41. 2008
    ..This article details the potent advantages and risks of concurrent use of adjuvant hormonotherapy and radiotherapy in localized breast cancers...
  31. ncbi [Adjuvant breast cancer treatment with hormono-radiotherapy]
    D Azria
    Département d Oncologie Radiothérapie, Inserm U896, CRLC Val d Aurelle Paul Lamarque, Montpellier, France
    Bull Cancer 96:285-9. 2009
    ....
  32. ncbi Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation
    M Ozsahin
    Department of Radiation Oncology, Hopital Tenon, Paris, France
    Int J Radiat Oncol Biol Phys 34:71-7. 1996
    ....